Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | APAF1 | O14727 | 1/20 | 0.75 |
| ▸ | RECQL | P46063 | 1/20 | 0.75 |
| ▸ | CASP6 | P55212 | 1/20 | 0.75 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.75 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.75 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.75 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.75 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.73 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.73 |
| ▸ | FABP4 | P15090 | 3/20 | 0.73 |
| ▸ | FABP3 | P05413 | 2/20 | 0.73 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.73 |
| ▸ | CDC25B | P30305 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | CLCN2 | P51788 | 2/20 | 0.62 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.58 |
| ▸ | PIM1 | P11309 | 1/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.58 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30638203 | 1.00 | KDM4E (0.75) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL11648254 | 0.88 | AKR1C3 (0.76) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL1961597 | 0.87 | AKR1C3 (0.62) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL10935377 | 0.86 | AKR1C3 (0.65) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL30567368 | 0.86 | AKR1C3 (0.65) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL1720516 | 0.86 | KDM4E (1.00) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL29441241 | 0.86 | KDM4E (1.00) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL14376023 | 0.86 | AKR1C3 (0.82) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL13271379 | 0.85 | FABP3 (0.68) | KDM4EAPAF1RECQLCASP6CACNA1B | |
| SCHEMBL28565067 | 0.85 | FABP4 (1.00) | KDM4EAPAF1RECQLCASP6CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4921875-A | Use of amino-substituted benzoic acids as remedies for diarrhea, and medicaments based on these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-01 | — | — | US | claimed |
| CN-111057004-B | N-o-substituted phenyl benzamide-4-methylaminoacridine compound and preparation method and application thereof | 宁波大学 | 2023-10-31 | — | — | CN | disclosed |
| CN-111057004-A | N-ortho-substituted phenyl benzamide-4-methylaminoacridine compound and preparation method and application thereof | 宁波大学 | 2020-04-24 | — | — | CN | disclosed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20070031854-A1 | Novel 10,10'-substituted-9,9'-biacridilidine luminescent molecules their preparation and uses | KATSILOMETES GEORGE W | 2007-02-08 | — | — | US | disclosed |
| US-20020034828-A1 | NOVEL 10,10'-SUBSTITUTED-9,9'-BIACRIDINE LUMINESCENT MOLECULES AND THEIR PREPARATION | PIERCE CHEMICAL COMPANY | 2002-03-21 | — | — | US | disclosed |
| EP-0737722-B1 | New indoaniline metal complex, process for their production, and transparent recording medium and optical recording medium by use thereof | JUJO PAPER CO LTD (JP) | 2001-07-04 | — | — | EP | disclosed |
| EP-1026156-A2 | Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation | PIERCE CHEMICAL COMPANY (US) | 2000-08-09 | — | — | EP | disclosed |
| US-5919928-A | Phenanthridine derivatives and metal complexes thereof used for transparent recording medium or optical recording medium | NIPPON PAPER INDUSTRIES, CO., LTD. (JP) | 1999-07-06 | — | — | US | disclosed |
| US-5892042-A | OPTICAL RECORDING MEDIA WITH ACRIDINE DYES ON TRANSPARENT SUBSTRATE | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 1999-04-06 | — | — | US | disclosed |
| US-5792863-A | HAVING LARGE ABSORPTION IN NEAR INFRARED, REDUCED ABSORPTION IN VISIBLE RANGE | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0737722-A2 | New indoaniline metal complex, process for their production, and transparent recording medium and optical recording medium by use thereof | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 1996-10-16 | — | — | EP | disclosed |
| US-4629735-A | ANTIASTHMATIC AGENTS | STERLING DRUG INC. (US) | 1986-12-16 | — | — | US | disclosed |
| US-4549016-A | LIPOXYGENASE INHIBITORS, ANTIALLERGENS, ANTIASTHMA AGENTS | STERLING DRUG INC. (US) | 1985-10-22 | — | — | US | disclosed |
| US-4539429-A | LIPOXYGENASE INHIBITORS, ANTIASTHMA | STERLING DRUG INC. (US) | 1985-09-03 | — | — | US | disclosed |
| US-4515980-A | LIPOXYGENASE INHIBITORS | STERLING DRUG INC. (US) | 1985-05-07 | — | — | US | disclosed |
| US-4510139-A | ANTYIALLERGENS; ASTHMA | STERLING DRUG INC. (US) | 1985-04-09 | — | — | US | disclosed |
| US-4496590-A | TREATMENT OR PREVENTION OF ALLERGIC ASTHMA, ANTI-ASTHMATIC | STERLING DRUG INC. (US) | 1985-01-29 | — | — | US | disclosed |
| EP-0122518-A1 | Phenylaminobenzenealkanols and preparation | STERLING DRUG INC. (US) | 1984-10-24 | — | — | EP | disclosed |
| US-4168312-A | Quinolone derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | CLIC1, ASIC1, CLIC4 | KDM4E 3594/4885APAF1 922/4885RECQL 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.